Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer

<p>Suppl. Tables S1-S8</p>

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Gary N. Schwartz (16005870) (author)
Andere auteurs: Peter A. Kaufman (16005873) (author), Karthik V. Giridhar (16005876) (author), Jonathan D. Marotti (16005879) (author), Mary D. Chamberlin (15036341) (author), Bradley A. Arrick (16005882) (author), Grace Makari-Judson (16005885) (author), Matthew P. Goetz (8863130) (author), Shannon M. Soucy (16005888) (author), Fred Kolling (16005891) (author), Eugene Demidenko (16005894) (author), Todd W. Miller (16005897) (author)
Gepubliceerd in: 2025
Onderwerpen:
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
_version_ 1849927631957393408
author Gary N. Schwartz (16005870)
author2 Peter A. Kaufman (16005873)
Karthik V. Giridhar (16005876)
Jonathan D. Marotti (16005879)
Mary D. Chamberlin (15036341)
Bradley A. Arrick (16005882)
Grace Makari-Judson (16005885)
Matthew P. Goetz (8863130)
Shannon M. Soucy (16005888)
Fred Kolling (16005891)
Eugene Demidenko (16005894)
Todd W. Miller (16005897)
author2_role author
author
author
author
author
author
author
author
author
author
author
author_facet Gary N. Schwartz (16005870)
Peter A. Kaufman (16005873)
Karthik V. Giridhar (16005876)
Jonathan D. Marotti (16005879)
Mary D. Chamberlin (15036341)
Bradley A. Arrick (16005882)
Grace Makari-Judson (16005885)
Matthew P. Goetz (8863130)
Shannon M. Soucy (16005888)
Fred Kolling (16005891)
Eugene Demidenko (16005894)
Todd W. Miller (16005897)
author_role author
dc.creator.none.fl_str_mv Gary N. Schwartz (16005870)
Peter A. Kaufman (16005873)
Karthik V. Giridhar (16005876)
Jonathan D. Marotti (16005879)
Mary D. Chamberlin (15036341)
Bradley A. Arrick (16005882)
Grace Makari-Judson (16005885)
Matthew P. Goetz (8863130)
Shannon M. Soucy (16005888)
Fred Kolling (16005891)
Eugene Demidenko (16005894)
Todd W. Miller (16005897)
dc.date.none.fl_str_mv 2025-11-25T13:30:20Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30709482
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Supplementary_Tables_1-8_from_Alternating_17_-Estradiol_and_Aromatase_Inhibitor_Therapies_Is_Efficacious_in_Postmenopausal_Women_with_Advanced_Endocrine-Resistant_ER_sup_sup_Breast_Cancer/30709482
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Therapeutic Research and Development
Clinical Research and Trials
Breast Cancer
Clinical Trial Results
Translational Research
dc.title.none.fl_str_mv Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Suppl. Tables S1-S8</p>
eu_rights_str_mv openAccess
id Manara_ba396be64428a30f41e85bff020e333d
identifier_str_mv 10.1158/1078-0432.30709482
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30709482
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast CancerGary N. Schwartz (16005870)Peter A. Kaufman (16005873)Karthik V. Giridhar (16005876)Jonathan D. Marotti (16005879)Mary D. Chamberlin (15036341)Bradley A. Arrick (16005882)Grace Makari-Judson (16005885)Matthew P. Goetz (8863130)Shannon M. Soucy (16005888)Fred Kolling (16005891)Eugene Demidenko (16005894)Todd W. Miller (16005897)CancerTherapeutic Research and DevelopmentClinical Research and TrialsBreast CancerClinical Trial ResultsTranslational Research<p>Suppl. Tables S1-S8</p>2025-11-25T13:30:20ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709482https://figshare.com/articles/dataset/Supplementary_Tables_1-8_from_Alternating_17_-Estradiol_and_Aromatase_Inhibitor_Therapies_Is_Efficacious_in_Postmenopausal_Women_with_Advanced_Endocrine-Resistant_ER_sup_sup_Breast_Cancer/30709482CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307094822025-11-25T13:30:20Z
spellingShingle Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
Gary N. Schwartz (16005870)
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Breast Cancer
Clinical Trial Results
Translational Research
status_str publishedVersion
title Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
title_full Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
title_fullStr Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
title_full_unstemmed Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
title_short Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
title_sort Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
topic Cancer
Therapeutic Research and Development
Clinical Research and Trials
Breast Cancer
Clinical Trial Results
Translational Research